A Case of Pulmonary Nontuberculous Mycobacteriosis Induced by Tocilizumab Treatment for Rheumatoid Arthritis

DOI Web Site Web Site PubMed 15 References Open Access
  • INAYAMA Mami
    Department of Respiratory Medicine, National Hospital Organization Kochi National Hospital
  • SHINOHARA Tsutomu
    Department of Respiratory Medicine, National Hospital Organization Kochi National Hospital
  • HOSOKAWA Emiko
    Department of Respiratory Medicine, National Hospital Organization Kochi National Hospital
  • MACHIDA Hisanori
    Department of Respiratory Medicine, National Hospital Organization Kochi National Hospital
  • IWAHARA Yoshihito
    Department of Respiratory Medicine, National Hospital Organization Kochi National Hospital
  • OGUSHI Fumitaka
    Department of Respiratory Medicine, National Hospital Organization Kochi National Hospital

Bibliographic Information

Other Title
  • トシリズマブによる関節リウマチ治療中に発症した非結核性抗酸菌症の 1 例
  • 症例 トシリズマブによる関節リウマチ治療中に発症した非結核性抗酸菌症の1例
  • ショウレイ トシリズマブ ニ ヨル カンセツ リウマチ チリョウ チュウ ニ ハッショウ シタ ヒケッカクセイ コウサンキンショウ ノ 1レイ

Search this article

Description

A 65-year-old woman whose rheumatoid arthritis was treated with tocilizumab (TCZ) was found in chest radiography to have a new consolidation in the right lower lung field. Positive Mycobacterium intracellulare and Mycobacterium avium cultures in sputum and bronchial secretions yielded a diagnosis of pulmonary nontuberculous mycobacteriosis. The most common adverse TCZ effect is infection. This case highlights the fact that those treated with TCZ should be considered at elevated risk for developing nontuberculous mycobacteriosis.

Journal

  • Kansenshogaku Zasshi

    Kansenshogaku Zasshi 85 (5), 523-526, 2011

    The Japanese Association for Infectious Diseases

References(15)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top